Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Genetically-altered adult stem cells can help in wound healing and are becoming crucial in regenerative medicine and drug design.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Experts suggest various surgical methods for hair restoration, including scalp reduction, transplantation using minigrafts, and establishing a permanent frontal hairline with follicular units. The drug finasteride may also be used alongside these procedures.

BroadAMP-GPT effectively creates antimicrobial peptides to fight drug-resistant bacteria.

Cyclodextrins improve finasteride's solubility and bioavailability for hair loss treatment.

The 39th Manfred Donike Workshop discussed methods for detecting misuse of steroids, gene doping, and the complexity of identifying drug residues in urine, highlighting the ongoing efforts to improve global anti-doping work.

TheDES improve drug delivery through the skin but need more safety checks.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

Compound 6 is a promising candidate for better wound healing.

Finasteride may increase depression by reducing brain cell growth.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Baicalin may help treat severe drug-induced skin reactions.

Integrating biological networks improves drug repurposing and ADR prediction.

Finasteride effectively treats male hair loss, improving growth and density.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Nanogels with hydrophobic modifications improve oral drug delivery for intestinal disease treatment.

Nanovesicles improve drug delivery through the skin, offering better treatment outcomes and fewer side effects.

Cyclodextrin-grafted polysaccharides improve drug delivery and pollutant removal, offering sustainable solutions for medicine and the environment.

Nanoparticle-based dressings and theranostic innovations improve chronic wound care by effectively targeting biofilms and offering precise treatment.

The committee decided not to approve the drug due to low effectiveness and high risks.

Topical Vorinostat shows promise for treating alopecia areata by promoting hair regrowth.

Liposomes could improve how skin care products work but are costly and not very stable.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Adapalene, Diosmin, and Azelastine could be repurposed to treat onchocerciasis.

Organic and biogenic nanocarriers can improve drug delivery but face challenges like consistency and safety.

The AUTS2 gene is linked to neurological disorders and may affect human brain development and cognition.

Peptide hydrogels are promising for drug delivery and tissue repair in medicine.